Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Essential Hypertension”

81 trials

Showing 20 of 81 results

Testing effectiveness (Phase 2)Study completedNCT01878201
What this trial is testing

A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 75
Large-scale testing (Phase 3)Study completedNCT00857285
What this trial is testing

Olmesartan Medoxomil Versus Losartan in Patients With Hypertension

Who this might be right for
Essential Hypertension
Daiichi Sankyo 130
Large-scale testing (Phase 3)UnknownNCT06141200
What this trial is testing

NW Roselle in Grade 1 Essential Hypertension: Phase III Clinical Trial

Who this might be right for
Essential Hypertension
Natural Wellness Egypt 286
Large-scale testing (Phase 3)Study completedNCT00400218
What this trial is testing

Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension (0954A-323)

Who this might be right for
Hypertension
Organon and Co 62
Post-approval studies (Phase 4)Study completedNCT05521282
What this trial is testing

The Efficacy of Qianglidingxuan Tablets in the Treatment of Hypertension

Who this might be right for
HypertensionMedicine, Chinese Traditional
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 269
Early research (Phase 1)Not Yet RecruitingNCT07152444
What this trial is testing

A Phase I Trial of QLS1410 in Healthy Chinese Adults and Participants With Mild Essential Hypertension

Who this might be right for
Uncontrolled Hypertension
Qilu Pharmaceutical Co., Ltd. 78
Large-scale testing (Phase 3)Study completedNCT01672476
What this trial is testing

A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boryung Pharmaceutical Co., Ltd 293
Large-scale testing (Phase 3)Study completedNCT05359068
What this trial is testing

Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Shanghai Pharmaceuticals Holding Co., Ltd 957
Post-approval studies (Phase 4)UnknownNCT02641821
What this trial is testing

Effect of Nifedipine GITS in Patients With Mild-to-moderate Primary Hypertension

Who this might be right for
Hypertension
Peking University First Hospital 700
Large-scale testing (Phase 3)Study completedNCT00236665
What this trial is testing

Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential Hypertension

Who this might be right for
ObesityHypertension
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 531
Very early researchStudy completedNCT05095350
What this trial is testing

Effect of Probiotics on Primary Hypertension

Who this might be right for
Hypertension
Chinese Academy of Medical Sciences, Fuwai Hospital 115
Large-scale testing (Phase 3)Study completedNCT01001572
What this trial is testing

Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Novartis 932
Large-scale testing (Phase 3)Not Yet RecruitingNCT06771245
What this trial is testing

A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive Patients

Who this might be right for
Mild-to-moderate Essential Hypertension
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 606
Testing effectiveness (Phase 2)Study completedNCT03756103
What this trial is testing

Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients

Who this might be right for
Hypertension,Essential
Shanghai Pharmaceuticals Holding Co., Ltd 120
Large-scale testing (Phase 3)Study completedNCT00367094
What this trial is testing

Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Novartis 296
Testing effectiveness (Phase 2)Study completedNCT00922441
What this trial is testing

A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 92
Large-scale testing (Phase 3)Study completedNCT00139698
What this trial is testing

Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Pfizer 410
Post-approval studies (Phase 4)Study completedNCT00333489
What this trial is testing

Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension

Who this might be right for
Hypertension
Novartis 551
Large-scale testing (Phase 3)UnknownNCT00644475
What this trial is testing

Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension

Who this might be right for
Essential Hypertension
University of Pavia 60
Not applicableStudy completedNCT00218972
What this trial is testing

Physical Exercise in Hypertension, Randomised Clinical Trial

Who this might be right for
Hypertension
Norwegian University of Science and Technology 88
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation